Effectiveness and cost effectiveness of cognitive behavioral therapy (CBT) in clinically depressed adolescents: individual CBT versus treatment as usual (TAU) by Stikkelbroek, Y.A.J. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/130148
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
STUDY PROTOCOL Open Access
Effectiveness and cost effectiveness of cognitive
behavioral therapy (CBT) in clinically depressed
adolescents: individual CBT versus treatment as
usual (TAU)
Yvonne Stikkelbroek*, Denise HM Bodden, Maja Deković and Anneloes L van Baar
Abstract
Background: Depressive disorders occur in 2 to 5% of the adolescents and are associated with a high burden of
disease, a high risk of recurrence and a heightened risk for development of other problems, like suicide attempts.
The effectiveness of cognitive behaviour therapy (CBT), cost-effectiveness of this treatment and the costs of illness
of clinical depression in adolescents are still unclear. Although several Randomized Controlled Trials (RCT) have been
conducted to establish the efficacy of CBT, the effectiveness has not been established yet. Aim of this study is to
conduct a RCT to test the effectiveness of CBT and to establish the cost-effectiveness of CBT under rigorous
conditions within routine care provided by professionals already working in mental health institutions.
Method/Design: CBT is investigated with a multi-site, RCT using block randomisation. The targeted population
is 140 clinically referred depressed adolescents aged 12 to 21 years old. Adolescents are randomly assigned to
the experimental (N = 70, CBT) or control condition (N = 70, TAU). Four assessments (pre, post, follow up at 6
and 12 months) and two mediator assessments during treatment are conducted. Primary outcome measure is
depression diagnosis based on a semi-structured interview namely the K-SADS-PL. Secondary outcome measures
include depressive symptoms, severity and improvement of the depression, global functioning, quality of life, suicide
risk, comorbidity, alcohol and drug use, parental depression and psychopathology, parenting and conflicts. Costs and
treatment characteristics will also be assessed. Furthermore, moderator and mediator analyses will be conducted.
Discussion: This trial will be the first to compare CBT with TAU under rigorous conditions within routine care and with
a complex sample. Furthermore, cost-effectiveness of treatment and cost-of-illness of clinical depression are established
which will provide new insights on depression as a disorder and its treatment.
Trial registration: Dutch Trial register number NTR2676. The study was financially supported by a grant from ZonMw,
the Netherlands organization for health research and development, grant number 157004005.
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Background
Depressive disorders in adolescents are among the most
prevalent disorders with a high burden of disease [1] and
high risk of recurrence [2,3]. Before entering adulthood,
14 to 25% of the adolescents have experienced at least one
episode of a depressive disorder [2]. Besides the high
prevalence [4-7], comorbid psychiatric diagnoses are often
present [8-10]. In addition, a heightened risk exists for
development of social problems, juridical problems, learn-
ing problems, substance abuse, negative life events, physical
problems, teen pregnancies and suicide [2,9,11]. Therefore,
it is important that depression is treated in an early stage
with an effective treatment [2,12].
In the international literature, there is no consensus
on the degree of effectiveness of psychotherapeutic in-
terventions in depressed adolescents. In a meta-analysis,
which included studies with a large diversity of investi-
gated interventions, only a modest effect size of 0.34 was
found [13]. Other meta-analyses calculated medium (0.72)
[14] to large (1.27) effect sizes [15]. In a meta-analysis
solely directed at Cognitive Behavioral Therapy (CBT) a
medium effect size of 0.53 was found [16]. Although the
effect size for CBT is promising, it also reflects the need
for improved treatment of depression, as a large group
of depressed adolescents will not recover after CBT
treatment.
In addition, it is often discussed that effectiveness studies
in depressed adolescents lack generalizability for clinical
practice, because the study samples do not match the
complex and severe cases in routine mental health care
[13]. In this study, this issue is addressed by comparing
CBT to treatment as usual within a referred clinically
depressed group of adolescents.
Within this study an individual revision of the group
CBT program “Coping with Depression course for
Adolescents” (CWD-A) [17] will be investigated. Group
CBT was adapted into an individual CBT format because
it is much better applicable within mental health care
than group CBT, for instance children can start treat-
ment immediately. Several RCT’s were conducted with
an American population, but not with clinically referred
adolescents. Results repeatedly have shown that the CWD-A
was more effective than control conditions [18,19] and
treatment as usual [20,21]. As only one research group
investigated the CWD-A, it is regarded as probably effi-
cacious [22].
The costs of depression in adolescents have not been
studied before. Knowledge about costs of depression is
essential to motivate an increase in budgets for treatments.
A recent cost-of-illness study on children with anxiety dis-
orders shows that both the costs of school absence, as
well as productivity loss of the parents are substantial
[23]. Given the high degree of comorbidity of anxiety and
depression and the fact that both disorders are internalising
disorders, the same high costs are expected in adolescents
with depression. Lynch and colleagues [24] investigated
cost-effectiveness of a group based prevention course
“Coping with Stress” in adolescents with a subclinical
depression. It was concluded that group CBT was more
cost effective in comparison to treatment as usual. How-
ever, intervention related costs like productivity costs,
expressed as school absence, were not taken into account.
Including these costs could indicate that cost-effectiveness
is even higher.
Within intervention research in depressed adolescents,
little is known about possible moderators and mediators
of treatment. A lot of authors mention the necessity to
investigate factors that may be involved as such [13,22].
In conclusion, the efficacy of CBT for the treatment of
clinically depressed adolescents is established, but the
effectiveness is not yet clear. Cost effectiveness of CBT
in comparison to Treatment As Usual (TAU) and poten-
tially important moderators and mediators have not been
investigated yet. Effectiveness, cost effectiveness, and in-
formation on moderators and mediators are essential for
the enhancement of the treatment for depression in
adolescence in order to reduce the burden of adolescent
depression and recurrence.
Methods and design
Aim of the study
The aim of this study is to investigate the effectiveness
and the cost-effectiveness of the individual CBT program
the “D(o)epression course” in a sample of referred adoles-
cents with a Depressive Disorder according to DSM-IV-TR
[25] in a randomized controlled trial. We expect that CBT
will be more effective than TAU (without CBT). Further-
more, cost-effectiveness of CBT and the cost of illness of
clinical depression in adolescents will be established. Poten-
tial moderators (comorbidity, severity of depression, age,
ethnicity, gender, suicidal thoughts and psychopathology
in parents) and mediators (negative automatic thoughts,
cognitive emotion regulation and attribution style) for the
effectiveness of CBT will be studied. The role of non-
specific treatment variables (therapeutic alliance, client
expectancy, client satisfaction, treatment adherence) will
be taken into account as well (see Figure 1).
Design
This study is designed as a multi-site, randomized con-
trolled clinical trial in which individual CBT will be com-
pared to TAU. Four multiple informant (adolescent, parent,
therapist) assessments are done: prior to treatment (pre-test
assessment), immediately after treatment (post-test
assessment or after 15 sessions), 6 months after treat-
ment (6 month follow-up) and 1 year after treatment
(1 year follow-up). To investigate potential mediators
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two temporary assessments are conducted, each after 5
therapy sessions.
All sessions will take place within routine outpatient
care within second order public mental health clinics to
enhance external validity. All treatments in both condi-
tions are delivered by psychologists with at least a master's
degree-level and two years of experience within profes-
sional mental health care. These professionals are trained
before delivering the treatments to enhance treatment
integrity.
Adolescents who are diagnosed with a depression ac-
cording to the K-SADS-PL [26,27], who meet inclusion
criteria and do not meet the exclusion criteria are ran-
domly assigned to either individual CBT or TAU. Random
assignment per adolescent is executed using computer
generated block randomisation and stratified per mental
health centre. See Figure 2 for patient’s flow chart.
The design of this study is according to the guidelines
specified by the Task force on promotion and dissemin-
ation (1995) and approved by the independent Medical
Ethics Committee (METC) of the Utrecht Medical Centre
at Utrecht University.
Sample size
Based on previous research [16] an effect size (Cohen’s d)
of 0.53 is expected. Power calculations indicated that 70
adolescents per condition (assuming an alpha of 0.05, a
statistical power, 1-beta, of 0.80 and a drop-out of 20%;
power calculations in STATA) are required to detect a
difference in depression diagnosis. In total 140 adoles-
cents will be included.
Study sample
In total 140 referred clinically depressed adolescents aged
12 to 21 (n = 140) and their parents will be included in this
study. If the adolescent is 18 years or older, parents will
only be approached after the adolescent’s permission. The
inclusion criteria for the depressive adolescents are: (1) a
primary diagnoses of Depressive Disorder (regardless the
severity: mild, moderate or severe) or Dysthymic disorder,
(2) age 12 to 21 years, and (3) referred to one of the par-
ticipating mental health institutions. The exclusion criteria
are: (1) acute suicide risk, (2) drug abuse (as primary diag-
nosis), (3) pervasive developmental disorder (as primary
diagnosis), (4) bipolar disorder (as primary diagnosis), (5)
day care or admission to the clinical setting and (6) not
fluent in Dutch, Turkish, Arabic or Berber language. If
medication is used (for the depression or another dis-
order), the dosage should be kept constant during the
intervention, unless medication is the control treatment.
Participants in both groups will be compared afterwards
for their match on the following characteristics: age, ethni-
city, gender, educational level parents and severity of the
depression. If significant differences between two groups
appear, these variables will be controlled for in analyses.
Recruitment
The participants are recruited from fourteen different
specialized mental health care institutions spread all over
AIM 4 MODERATORS
1. Gender
2. Age
3. Ethnicity
4. Educational level
5. Family income
6. Depression severity
7. Comorbidity
8. Parental depression
9. Parental psychopathology AIM 1 OUTCOME MEASURES
1. Depression Diagnosis 
(presence)
2. Depression symptoms
3. Depression severity
4. Depression improvement
5. Global functioning
6. Quality of life
7. School or work
8. Suicide risk
9. Comorbidity
10. Alcohol and drugs use
11. Life events
12. Parental depression
13. Parental psychopathology
14. Parenting
15. Conflict
D(o)epression (CBT)
Treatment as usual (TAU)
versus
AIM 5 MEDIATORS
1. Automatic Cognitions 
2. Emotion regulation
3. Attribution style
AIM 2 + 3 COST MEASURES 
1. Cost questionnaire
Figure 1 Aims, conditions, potential moderators and mediators evaluated in this study.
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the Netherlands. An experienced psychologist within the
mental health centre informs the adolescents and their
parents about the study. After written informed consent
by the adolescent and his/her parents, a trained inde-
pendent researcher carries out an interview to check for
the inclusion and exclusion criteria.
Intervention
The experimental treatment is a protocolled individual
CBT program, the D(o)epressie course. It consists of 15
weekly sessions of 45 minutes, two parent sessions after
3 and 9 weeks and a meeting with the parent at the end
of treatment. The D(o)epressie course is, as the CWD-A,
based on the social learning theory about the aetiology
of depressions by Lewinsohn [28]. According to this
theory, there is a connection between the number of
positive interactions between a person and his environ-
ment on one hand, and depression on the other. A trig-
gering event such as a stressful life event causes a
negative spiral of less positive interactions leading to
more negative thoughts and a deteriorating depressed
mood. The aim of the intervention is to reduce depressive
complaints in adolescents with a depressive disorder.
Since depressive episodes are multi-factorial determined,
the focus of the intervention is broad. The intervention
contains representative components of CBT [29] namely:
psycho-education (information about depression and the
rationale for the aetiology of the complaints and the
treatment of them), setting attainable goals (translate
large goals into realistic short term goals), self monitor-
ing (registration of the mood, activities and thoughts),
activation (planning frequent, joyful activities), improv-
ing social skills and communication skills (improvement
and stimulation of social behaviour), relaxation techniques,
cognitive restructuring (identifying and changing un-
realistic negative thoughts about the self, others and
events), role play and problem solution skills (teaching
the creation of solutions for problems via brainstorm,
1. Referral, intake process and diagnostics
2. Does the client meet inclusion and exclusion criteria?
3. Yes, information is given about the study
4. Yes, informed consent
CBT (n = 70) TAU (n = 70)
10. Posttest (after 15 sessions or 20 weeks)
11. 6 month follow-up  (6 months after posttest)
3. No, exclusion from study
4. No, exclusion from study
6. Randomisation (n =140)
5. Pretest
7. Start Intervention
8. After 5 sessions; mediator test 1
9. After 10 sessions; mediator test 2
Permission asked to use diagnostic data
12. 12 month follow-up  (12 months after posttest)
Therapist
fills 
in 
the 
TPC 
each 
session
Figure 2 Participants’ flow through the study.
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choosing, trying and evaluating) and relapse prevention.
Exercises are executed within the sessions and are gen-
eralised into daily life by means of homework assign-
ments. In the parent sessions, parents will receive psycho
education and information on CBT. Therapists are not
allowed to conduct treatments in both conditions.
The control treatment consists of TAU for clinical de-
pression. After a short telephone survey we concluded
that TAU in the Netherlands consists of: Interpersonal
Therapy (IPT), family therapy, parent counselling, medica-
tion, mindfulness training, acceptance commitment therapy
(ACT), psychodynamic therapy (short duration), (non-
directive) counselling, creative therapy and running ther-
apy, and CBT. However, in this study CBT is not allowed
within TAU. The content of TAU and the treatment tech-
niques used, are monitored.
Instruments
In Table 1, concepts, source and time of assessment of all
used instruments are presented. The adolescent and parent
complete the self-report questionnaires online at home.
Both, the adolescent and the parent have a separate login
code to secure privacy. The parents fill in a paper version
of the cost diary at home. The therapist completes the
questionnaires at the office.
Primary outcome measures
The primary outcome measure is the presence of the de-
pression diagnosis, as measured by the Kiddie-Schedule
for Affective Disorders and Schizophrenia, present and
lifetime version (K-SADS-PL) [26,27], a widely used semi-
structured diagnostic interview. The K-SADS-PL assesses
a wide range of diagnoses (present and life time) including
their severity. The view of the adolescent, the parent and
the independent clinician are taken into account. Con-
current validity of the K-SADS-PL is supported [26].
Also the interrater agreement is high (range 93% to 100%)
and test –retest reliability is excellent for present and life-
time diagnoses of major depression (.77 to 100) [26]. Con-
vergent validity of the depression screen criteria and the
diagnoses generated with the K-SADS-PL was confirmed
but divergent validity is only partly supported within an
inpatient sample [30].
Secondary outcome measures
A broad range of secondary outcome measures will be
assessed namely total symptoms of major depressive
disorder or dysthymic disorder, severity and improve-
ment of depression, global functioning, quality of life,
suicide risk, comorbidity, alcohol and drug use, parental
depression and psychopathology, parenting and con-
flicts. Costs, moderators, mediators and treatment char-
acteristics will be assessed as well.
The degree of depressive symptoms are measured with
a self report measure, the Child Depression Inventory-2
(CDI-2) [31,32]. The CDI-2 is a revision of the CDI
[33,34] and was translated in Dutch. It was expanded with
a version for the parents (CDI-P) [31] as well. The severity
of the depression is rated by the independent clinician on
the K-SADS-PL (see above) and by the therapist on the
Clinical Global Impression-severity scale (CGI-S) [35].
Improvement of depression, in reference to the severity
of the depression at the start of the treatment, is also
rated by the therapist on the Clinical Global Improve-
ment scale (CGI-I) [35]. Global functioning of the adoles-
cent is measured by an independent clinician and therapist
on the Children Global Assessment Scale (CGAS) [36,37].
The Dutch version of the EuroQol Questionaire (EQ-5D
adolescent and parent version) [38] is used to establish
quality of life as expressed in quality adjusted life years
(QALYs). Apart from the K-SADS-PL, suicide risk is also
assessed with a newly developed self-report questionnaire,
which focuses on frequency of suicidal thoughts, wishes,
plans and actions over the past two weeks.
Comorbidity and psychopathology is assessed with the
K-SADS-PL, but also with the Youth Self Report scale
(YSR) for adolescents and the Child Behavior Check List
(CBCL) for parents [39,40]. Comorbidity between depres-
sion and anxiety is very high [12] therefore anxiety symp-
toms are also assessed separately with the Scared-5 [41].
Personality of the adolescent is assessed with the Quick
Big Five Personality Inventory (QBF) [42]. For this study,
we also constructed the Life Event Scale (LES) [43], which
is a self-report measure about life events (including drug
abuse, bereavement, maltreatment and suicide attempts),
their date of occurrence and their impact on the adoles-
cents well being.
Psychopathology of both parents is measured with the
Adult Self-Report (ASR) [44]. The degree of depressive
symptoms in parents is assessed with the Dutch version of
the Beck Depression Inventory, second edition (BDI-II-
NL) [45,46].
Parenting, in particular consistency, responsiveness, posi-
tive parenting, harsh discipline, psychological control and
behavioral control is assessed with subscales of different
instruments filled in by both the adolescent and the
parent. The Parenting Dimensions Inventory (PDI) [47,48]
was used to measure consistency, the degree to which
the parent shows predictable discipline behaviour. The
Nijmeegse Rearing Questionnaire (NOV) [49,50] mea-
sures responsiveness, the degree to which the parent is
responsive for the needs, signals and condition of the
child, and attachment, the degree to which the parent feels
emotionally connected to the child. Positive parenting is
measured with 6 items from the Alabama Parenting
Questionnaire (APQ) [51]. The Ghent Parental Behavior
Questionnaire (SOG) [52] assesses physical harsh discipline
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Table 1 Instruments at different assessments and informants
Domain/concept Instrument Items Source Test
A. P. T. Pre Med Post Fu1 Fu2
Primary outcome Depression diagnosis K-SADS x x x x x x
Secondary outcomes Depression symptoms CDI-II 28/17 x x x x x x x
Depression severity KSADS x x x x x x
CGI-S 1 x x x x
Depression Improvement CGI-I 1 x x x x
Global functioning CGAS 1 x x x x
Quality of life EuroQol 6 x x x x x x x
School or work SQ 7 x x x x x
Suicide Risk Taxation SRT 6 x x x x x
Comorbidity K-SADS x x x x x x
YSR 69 x x x x x
CBCL 74 x x x x x
SCARED 5 x x x x x x
Alcohol and drug use AD 7 x x x x x
Personality Big 5 30 x x x
Life events LES 23 x x x x x x
Parental depression BDI-II 21 x x x x x
Parental Psychopathology ASR 69 x x x x x
SCARED 4 x x x x x
Parenting x x x x
-Responsivity NOV 8
-Consistency PDI 8
-Positive parenting APQ 6
-Harsh discipline SOG 8
-Psychological control PCS 8
-Behavioural control VTH 6
Competence NOSI 5 x x x
Attachment PARA 13 x x x x
Conflict NRI 6 x x x x x x
Cost-effectiveness Costs Cost questionnaire x x x x x
Quality of life EuroQol x x x x x x x
Moderators Demographic Gender 8/12 x x x x x x
Characteristics adolescent Age
Ethnicity
Education
Income
Depression severity K-SADS x x x x x x
Comorbidity YSR x x x x x
CBCL x x x x x
Parental depression BDI x x x x x
Parental Psychopathology ASR x x x x x
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or physical punishment. Psychological control is assessed
using the Psychological Control Scale (PCS) [53], which
measures the degree in which the parent tries to control
the child in an intrusive way. The degree in which parents
monitor their children, that is behavioral control is mea-
sured with 6 items of the (Monitoring questionnaire, VTH)
[54]. Competence, the parents’ perspective on their ability
to address rearing practices, is established with the sub-
scale competence of the Nijmeegse Parental Stress Index
(NOSI) [55,56].
Attachment from child to parent is measured using
13 items of the Psychological Availability and Reliance
on Adult (PARA) [57]. The degree of conflicts (quarrels,
irritations and antagonism in the child–parent relation-
ship) was measured with 6-item Network of relationship
inventory (NRI) [58].
The economic evaluation is done by registration of costs
in a cost diary based on the Trimbos Institute and Insti-
tute of Medical Technology Assessment Questionnaire
on Costs Associated with Psychiatric Illness (TiC-P) [59]
and PRODISQ [60]. The registered costs are directly
related to health care or indirect health care (out-of-
pocket costs, costs of informal care) and direct costs
outside health care (monetary value of production losses
caused by absence and reduced productivity). The costs
will be considered separately from the perspective of
mental health and from society. The mental health costs
are the costs, which are credited to the mental health
care budget, the decision-maker’s perspective. The soci-
etal costs are the costs of direct (mental) health care as
well as indirect costs such as lost productivity, school
absent and out-of-pocket costs.
Potential moderators that are analysed are severity of
the depression, comorbidity, parental depression and psy-
chopathology and demographic variables. Demographic
information is gathered by adding questions about gen-
der, age, ethnicity, education level and family income to
the self-report questionnaires.
Three mediators are investigated namely negative auto-
matic thoughts (CNCEQ) [61], cognitive emotion regula-
tion (CERQ) [62] and attribution style (CASQ) [63]. The
Cognitive Negative Cognitive Error Questionnaire (CNCEQ)
measures cognitive errors namely the underestimation
of the ability to cope, personalizing without mind read-
ing, selective abstraction, over generalizing and mind
reading. The Cognitive Emotion Regulation Questionnaire
(CERQ) measures a broad set of cognitive emotion
regulation strategies which are used in response to the
experience of threatening or stressful life events; Self-
blame, Other-blame, Rumination, Catastrophizing, Posi-
tive refocusing, Planning, Positive reappraisal, Putting into
perspective and Acceptance. The Children’s Attributional
Style Questionnaire (CASQ) is a self-report measure with
three dimensions of attribution; internal- external, stable-
unstable and global- specific.
Several non-specific treatment variables will be investi-
gated. The client’s credibility, expectancy and involvement
regarding treatment are assessed with the Parent Expect-
ancies for Therapy Scale (PETS) [64] which was revised
for adolescents. Previous treatments for depression, in-
cluding complementary and self-help treatments, are
administered with the inventory of History of Treatments
(VEHI) [65]. Satisfaction with treatment is measured with
the Service Satisfaction Scale (SSS) [66]. The Cooperation
With Treatment scale (CWT) [67] is used to assess the
degree of cooperation with treatment as observed by the
therapist. The quality of the therapeutic alliance is assessed
with the Therapy Alliance Scale for Adolescents (TASC)
[68]. The content of treatment is assessed in both condi-
tions with the Therapy Procedure Checklist (TPC) [69].
Treatment integrity will be established by recording two
randomly chosen sessions that are observed and rated.
Statistical analyses
Missing values will be imputed. Intent-to-treat as well as
completer analyses will be conducted. The effect of the
Table 1 Instruments at different assessments and informants (Continued)
Mediators Negative automatic thoughts CNCEQ 16 x x x x x x
Cognitive Emotion regulation CERQ 36 x x x x x x
Attribution style CASQ 24 x x x x x x
Treatment characteristics Expectancy of treatment PETS 7 x x x
Previous treatment VEHI 8 x x x x x x
Satisfaction with treatment SSS 4 x x x
Cooperation with treatment CWT 5 x x x
Relationship with therapist RWI 13 x x x
Treatment Integrity observations x
Therapy Procedures Checklist TPC 51 x Each session
Preferred treatment 1 x x
Abbreviations: A adolescent, FU1 Follow-up1, FU2 Follow-up2, Med1 mediatortest1, Med2 mediatortest2, Post posttest, P parents, Pre pretest, T therapist.
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intervention is analyzed with a chi-square test on the
dichotomous primary outcome measure, presence of the
depression diagnosis (K-SADS-PL). The cost-effectiveness
analyses will be based on the comparison of costs and
effects in both conditions and will be done according
the international guidelines [70]. The cost- effectiveness
analyses will be done separately from the perspective
of mental health and society over a period of 6 months
and 1 year. The effects of societal costs will be expressed
in years to live, corrected for quality of life (QALYs). The
costs of CBT versus CAU will be expressed in 1) incre-
mental costs per QALY and 2) incremental costs per
adolescent with a depression in full remission.
The secondary continuous outcome measures will be
analyzed with repeated measures MANCOVA using the
pre-test as a covariate as is recommended for RCT’s with
pre-, post- and follow-up measurements [71]. For each
questionnaire, the effect size (Cohen’s d) from pre- to
post-treatment is defined as (Mpre-Mpost)/SDpooled, where
SDpooled = [(SDpre
2 + SDpost
2 )/2]. CBT versus TAU pre-post
effect sizes are calculated as follows [(MCBT post-MTAU post)/
SDpooled post] – [ (MCBT pre-MTAU pre)/SDpooled pre]. Further-
more, analyzes will be conducted to establish clinical
significance and the reliable change index [72].
Moderators will be analysed by multi-group analyses
for dichotomous variables. The continuous variables will
be analysed using hierarchic regression analyses. Medi-
ator effects will be analysed using hierarchical regression
analyses and structural equation modelling.
Discussion
As Weisz [13] pointed out, it is not enough to replicate
studies to increase our knowledge of effective treatment
of adolescent depression. It is necessary to be innovative
and to go further and “pushing the boundaries of what
has been done” [13]. In this study the design is innova-
tive in several regards.
First, the target population consists of referred clinically
depressed adolescents and the treatment is conducted
within routine mental health care services with routine
care professionals, in the Netherlands. Therefore, CBT
is investigated under real life conditions.
Second, the control condition is an active condition,
namely treatment as usual (TAU) within routine clinical
care, not a waiting list condition or just one specific
treatment such as medication. TAU being the control
condition is a more rigorous test of effectiveness of CBT.
As a secondary spin off, the collected data will also enable
a detailed description of TAU without CBT.
Third, long term effects of CBT versus TAU will be
examined, up to one year post treatment. This is import-
ant because of possible sleeper effects [73] and recurrence
of depressive symptoms.
Fourth, cost-effectiveness was investigated for a group
CBT program “Coping with Stress”, but only in adoles-
cents with a subclinical depression and as a prevention
program [24]. Cost-effectiveness of CBT versus TAU in
adolescents with clinical depression to our knowledge is
not yet investigated. Also productivity losses have never
been taken into account. The cost-effectiveness is of
increased importance because of diminishing budgets
in mental health care. Perhaps even more important, in
this study the costs of clinical depression in adolescents
are determined.
Fifth, although it is very important to know why a
treatment works and for whom it works, few studies
actually addressed this topic. In this study potential
mediators and moderators will be investigated.
As a result of the design, we anticipate several prob-
lems, which may become limitations of this study if not
properly addressed. To ensure the quality of the study,
these problems and their solutions, which are under-
taken to minimize the limitations, are discussed.
First, content of TAU and the techniques used are
difficult to monitor. Assessment of the therapeutic pro-
cedures used during each session by the therapist, pro-
vides detailed information on the components of the
treatment. Also two sessions are recorded at random,
observed and rated in detail to assess content of treat-
ment and techniques used.
Second, comparing CBT to an active control condition
may lead to a lower mean effect size than CBT versus a
non-active control condition [13]. The TAU condition
in this study is heterogeneous and it contains also
evidence-based treatments such as Interpersonal therapy.
As a result the ES can be even smaller, so we increased
the power accordingly.
Third, to include 140 adolescents within 18 months,
cooperation with a large group of mental health institu-
tions is necessary. Furthermore, we try to minimize the
effort the adolescent and their parents have to put into
the study by using online assessments of the self-report
questionnaires, while ensuring secrecy. Since the K-SADS-
PL is assessed in vivo, not only self-report, but also ob-
servations by an independent clinician are taken into
account.
Fourth, non-response may be a huge problem because
of the multiple assessments and informants. Online
assessment enables the researchers to monitor the pro-
gress per assessment per informant. They can react imme-
diately to non-response and increase the response rate
accordingly. This transparent logistic process of data
collection, data transportation and data file construction
reduces the risk of mistakes, missing data and contrib-
utes to the quality of the data [74].
Fifth, as it is not allowed to conduct CBT within the
TAU condition it is inevitable that TAU is changed in
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this regard. This is a methodological problem, which
may lead to bias, but cannot be solved properly. Although
we are fully aware of this methodological problem we
accept it because of the advantages of an RCT in a natur-
alistic setting. The preferred choice of treatment by the
multidisciplinary team for every included depressed ado-
lescent is registered and enables us to take into account
the preferred choice of treatment.
Sixth, the total amount of face-to-face contact within
TAU can be different from CBT. Also the time period in
which the treatment is completed can differ within TAU
and CBT. The amount of face-to-face contact in minutes
and the time period of the treatment will be taken into
account as potential moderating factors.
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